Articles from Definitive Healthcare Corp.

FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built In’s 100 Best Places to Work in Boston, MA for 2025. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors both remote-first employers as well as companies in large tech markets across the U.S.

FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference.

Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization

FRAMINGHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2024, on Thursday, November 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement

Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities

FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.

Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights

Second quarter revenue grew 5% year-over-year to $63.7 million

FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices

FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Empowering healthcare and life science organizations with faster insights through seamless data sharing

Second annual report showcases Definitive Healthcare’s continued successes related to culture, governance, and the environment

FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference.

Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise

FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.

First quarter revenue grew 7% year-over-year to $63.5 million

FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2024, on Tuesday, May 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

Medtech commercial teams can now solve frontline sales challenges with exceptional data and streamlined workflows

FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, a ranking of the 50 highest growth companies in Massachusetts. This marks the second year in a row that Definitive Healthcare has won this award.

Fourth quarter revenue grew 9% year-over-year to $65.9 million

FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

Jason Krantz, Founder and Executive Chairman, to Serve as Interim CEO

FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of Carrie Lazorchak as Definitive Healthcare’s new Chief Revenue Officer, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted Ms. Lazorchak an inducement award consisting of 385,695 time-based restricted stock units (“RSUs”) effective November 1, 2023. This award was individually negotiated and was granted as an inducement material to Ms. Lazorchak’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Third quarter revenue grew 14% year-over-year to $65.3 million

FRAMINGHAM, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2023, on Thursday, November 2, 2023 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023.

FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced two changes to its Board of Directors. On September 6, 2023, Scott Stephenson, the former Chief Executive Officer of Verisk Analytics, joined the Board of Directors and the nominating and corporate governance committee of the Board, while Chris Mitchell, managing director of Spectrum Equity, stepped down from the Board of Directors.

FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with Definitive Healthcare’s acquisition of Populi, Inc. (“Populi”), effective September 6, 2023, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards consisting of 551,758 performance-based restricted stock units (“PSUs”) and 274,728 time-based restricted stock units (“RSUs”) to 30 former employees of Populi. These awards include 137,363 PSUs (the “Moschella PSUs”) and 201,467 RSUs (the “Moschella RSUs”) granted to William Moschella, as well as 45,788 PSUs (the “Salmon PSUs”) and 73,261 RSUs (the “Salmon RSUs”) granted to Nathan Salmon, which were individually negotiated. The awards were granted as an inducement material to such individuals’ commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

FRAMINGHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 21st Annual Global Healthcare Conference.

Acquisition broadens Definitive Healthcare’s suite of healthcare commercial intelligence solutions with new data, analytics, and visualization tools tailor-built for the provider market

Second quarter revenue grew 12% year-over-year to $61.0 million

New data includes more than 1.7 million updates to technology installations for hospitals, health systems, ambulatory surgery centers, and physician groups, with proprietary intelligence on both confirmed and inferred technology installations

Q2 2023 Earnings Call Moved to August 14, 2023

FRAMINGHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2023, on Thursday, August 3, 2023 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

New enhancements include a 5% increase in all-payor medical claims data, new intelligence on behavioral health, and a 50% increase in healthcare executive data

FRAMINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the Stifel 2023 Cross Sector Insight Conference in Boston, MA and the 43rd Annual William Blair Growth Stock Conference in Chicago, IL.

First annual report highlights Definitive Healthcare’s successful efforts related to culture, governance, and the environment

FRAMINGHAM, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the 51st Annual J.P. Morgan Global Technology, Media and Communications Conference.

First quarter revenue grew 18% year-over-year to $59.2 million 

Built on the Atlas Dataset, Atlas AI includes 11 analytics that use artificial intelligence, machine learning, and advanced data science to help customers compete and win in the healthcare market

FRAMINGHAM, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its first quarter ended March 31, 2023 financial results will be released on Thursday, May 4, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

Joint customers can integrate data from Definitive Healthcare’s Atlas Dataset in the Snowflake Data Cloud

Definitive Healthcare’s customers can now access data from Definitive Healthcare solutions in Salesforce

FRAMINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Raymond James 2023 Institutional Investors Conference.

Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million 

FRAMINGHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2022 financial results will be released on Thursday, February 23, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuum

Includes reference & affiliation data, all-payor & prescription claims, and medical experts to help clients analyze the healthcare market from nearly any vantage point

FRAMINGHAM, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, Rick Booth, will present at the 25th Annual Needham Growth Conference.

FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named one of the Top Places to Work in Massachusetts by The Boston Globe. Definitive Healthcare has now been recognized by The Boston Globe for a sixth consecutive year.

Third quarter revenue grew 33% year-over-year to $57.4 million

FRAMINGHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced Jon Maack has joined the company as President, effective November 3, 2022. Maack will report to Definitive Healthcare CEO Robert Musslewhite and have responsibility for product management, engineering, corporate strategy, and M&A.

FRAMINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its third quarter ended September 30, 2022 financial results will be released on Thursday, November 3, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

FRAMINGHAM, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has joined the United Nations Global Compact, the largest corporate sustainability initiative in the world.

Sastry Chilukuri joins Board of Directors and Randy Winn departs

New product integrates comprehensive analytics built by Analytical Wizards with industry-leading data from Definitive Healthcare in a single package for more than 20 therapy areas

Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the availability of Latitude Reporting, a new product that allows users to build in real-time custom patient cohorts targeting specific disease states. With Latitude Reporting, users can quickly perform iterative analysis on real-world data to gain actionable intelligence that accelerates their go-to-market strategy.

Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced initial public offering of 17,888,888 shares of its Class A common stock, which includes the full exercise by the underwriters of their option to purchase up to an additional 2,333,333 shares of its Class A common stock, at a public offering price of $27.00 per share. Aggregate gross proceeds to Definitive Healthcare were approximately $483 million, before underwriting discounts, commissions, and estimated offering expenses. Definitive Healthcare’s Class A common stock began trading on the Nasdaq Global Select Market under the ticker symbol “DH” on September 15, 2021.

Definitive Healthcare Corp. (“Definitive Healthcare”), an industry leader in healthcare commercial intelligence, today announced the pricing of its initial public offering of its Class A common stock. Definitive Healthcare is offering 15,555,555 shares of its Class A common stock at a price to the public of $27.00 per share. The underwriters have a 30-day option to purchase up to an additional 2,333,333 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.

Definitive Healthcare Corp. (“Definitive Healthcare”), an industry leader in healthcare commercial intelligence that commenced the roadshow for its proposed initial public offering of its Class A common stock on September 7, 2021, today announced that it has filed an amended registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) pursuant to which it is offering 15,555,555 shares of its Class A common stock at an increased expected offering price to the public of between $24 and $26 per share. Definitive Healthcare expects to grant the underwriters a 30-day option to purchase up to an additional 2,333,333 shares of its Class A common stock.